Tailored Web-Based Intervention for Cancer Patients and Family Caregivers
This R21 will be used to develop an individually tailored, interactive, web-based
intervention for cancer patients (lung, colorectal, breast, prostate) and their family
caregivers. This intervention is based on an efficacious, family-based program of care (the
FOCUS Program) that has been tested previously in three large randomized clinical trials
with positive outcomes for patients and their caregivers. In this R21 we will translate this
primarily face-to-face, family-based program to an internet-based version.
The objectives are: Objective 1. To develop an individually-tailored, interactive, web-based
and email-based, Family Involvement Module. We will conduct formative testing while
developing the module using qualitative data obtained from four focus groups. We will
conduct usability testing of the near final module with data obtained from qualitative
interviews with patients and caregivers as they complete web-based task assignments using a
"think aloud" protocol while they navigate the module. Objective 2. To conduct a Phase II
study with cancer patients and their family caregiver (N = 40 dyads) using baseline (Time 1)
and two-month follow-up assessments (Time 2). Between Times 1 and 2, all participants
jointly will complete the web-based Family Involvement Module. We will determine the
feasibility of delivering the web-based module and will obtain a process evaluation
completed by study participants. Data will be obtained from three large cancer centers using
established instruments, and analyzed with descriptive statistics and paired t-tests.
Findings from this R21 will provide data that are essential to test this innovative,
tailored, interactive web-based intervention with a larger sample in a R01.
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Quality of life
A preliminary assessment of the magnitude of the pilot intervention effects on patients' and family caregivers' level of quality of life (FACT-G Scale) will be conducted.
Baseline (Time 1) and 2 months (Time 2)
No
Laurel Northouse, PhD
Principal Investigator
University of Michigan School of Nursing
United States: Institutional Review Board
R21CA138725
NCT01415089
May 2009
June 2011
Name | Location |
---|---|
University of Michigan Comprehensive Cancer Center | Ann Arbor, Michigan 48109-0752 |
Barbara Ann Karmanos Cancer Institute | Detroit, Michigan 48201 |
Saint Joseph Mercy Hospital | Ann Arbor, Michigan 48106 |